Does PONATINIB Cause Benign prostatic hyperplasia? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Benign prostatic hyperplasia have been filed in association with PONATINIB (Iclusig). This represents 0.2% of all adverse event reports for PONATINIB.
15
Reports of Benign prostatic hyperplasia with PONATINIB
0.2%
of all PONATINIB reports
0
Deaths
14
Hospitalizations
How Dangerous Is Benign prostatic hyperplasia From PONATINIB?
Of the 15 reports, 14 (93.3%) required hospitalization.
Is Benign prostatic hyperplasia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PONATINIB. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does PONATINIB Cause?
Death (1,735)
Off label use (1,071)
Product dose omission issue (817)
Fatigue (687)
Rash (639)
Headache (553)
Pyrexia (542)
Nausea (466)
Hospitalisation (459)
Constipation (435)
What Other Drugs Cause Benign prostatic hyperplasia?
TADALAFIL (596)
TAMSULOSIN (304)
FINASTERIDE (266)
PANTOPRAZOLE (261)
PREDNISONE (257)
ALBUTEROL (254)
ASPIRIN (243)
TIOTROPIUM (235)
RAMIPRIL (193)
AMLODIPINE (179)
Which PONATINIB Alternatives Have Lower Benign prostatic hyperplasia Risk?
PONATINIB vs PONATINIB\PONATINIB
PONATINIB vs PONESIMOD
PONATINIB vs PORACTANT ALFA
PONATINIB vs PORFIMER
PONATINIB vs POSACONAZOLE